Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001373604-25-000127
Filing Date
2025-12-18
Accepted
2025-12-18 15:47:45
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 5884
  Complete submission text file 0001373604-25-000127.txt   7636
Mailing Address 65 E CEDAR - SUITE 2 ZIONSVILLE IN 46077
Business Address 65 E CEDAR - SUITE 2 ZIONSVILLE IN 46077 317-344-2447
BML Investment Partners, L.P. (Filed by) CIK: 0001373604 (see all company filings)

EIN.: 383708345 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A

Mailing Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011
Business Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011 (425) 620-8501
Athira Pharma, Inc. (Subject) CIK: 0001620463 (see all company filings)

EIN.: 453368487 | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-91705 | Film No.: 251582940
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)